Stay updated on BI 695500 Clinical Trial in RA: Efficacy, PK, Safety
Sign up to get notified when there's something new on the BI 695500 Clinical Trial in RA: Efficacy, PK, Safety page.

Latest updates to the BI 695500 Clinical Trial in RA: Efficacy, PK, Safety page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check20 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference0.9%
- Check27 days agoNo Change Detected
- Check48 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.0%
- Check62 days agoChange DetectedThe page has been updated to include new drug names, Rituxan® and MabThera®, and an EudraCT number, while significant trial objectives and detailed inclusion and exclusion criteria have been removed.SummaryDifference28%
- Check70 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check77 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
Stay in the know with updates to BI 695500 Clinical Trial in RA: Efficacy, PK, Safety
Enter your email address, and we'll notify you when there's something new on the BI 695500 Clinical Trial in RA: Efficacy, PK, Safety page.